One relies on the influence of CCL2-CCR2 signaling via inflammatory factor secretion in the tumor microenvironment, and the other is dependent on the interaction of membrane receptors with the BSG-FAK-ERK pathway. This evidence concerns the gene CCR2 and neoplasm.